Harrow (HROW) Share-based Compensation Growth (3y) (2013 - 2026)
Harrow (HROW) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.35% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 40.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 67.91% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -28.57% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 12.76% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 20.51% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.07% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.54% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 18.39% |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 32.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.94% |
| Dec 31, 2025 | 23.18% |
| Sep 30, 2025 | 19.17% |
| Jun 30, 2025 | -24.00% |
| Mar 31, 2025 | 31.23% |
| Dec 31, 2024 | 31.36% |
| Sep 30, 2024 | 37.22% |
| Jun 30, 2024 | 58.24% |
| Mar 31, 2024 | 69.57% |
| Dec 31, 2023 | 14.59% |
| Sep 30, 2023 | 69.63% |
| Jun 30, 2023 | 105.02% |
| Mar 31, 2023 | 45.24% |
| Dec 31, 2022 | 189.26% |
| Sep 30, 2022 | 68.62% |
| Jun 30, 2022 | 75.77% |
| Mar 31, 2022 | 41.41% |
| Dec 31, 2021 | 46.98% |
| Sep 30, 2021 | 41.26% |
| Jun 30, 2021 | 21.03% |